U of T researchers reach across fields to stop a silent, killer disease utoronto.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from utoronto.ca Daily Mail and Mail on Sunday newspapers.
Scientists from the Toronto General Hospital Research Institute in Canada, have developed a device that essentially reverses the effects of binge drinking
(MENAFN - The Conversation) Dr. Nickel is an Associate Professor of Community Health Sciences at the University of Manitoba, Research Scientist and Associate Director at the Manitoba Centre for Health Policy, Scientist at the Children s Hospital Research Institute of Manitoba, and Co-Director of the Manitoba Interdisciplinary Lactation Centre (MILC). Nickel received his Master of Public Health (MPH) degree in Community Health Sciences from the University of California, Los Angeles and his PhD in Maternal and Child Health Policy from the Gillings School of Global Public Health, the University of North Carolina at Chapel Hill.
Dr. Nickel is an applied population health scientist. He uses administrative data to conduct health and social policy research. Nickel s research program centres on examining how social and structural determinants impact population health and well-being and health and social inequities. Within this framework he has conducted evaluation research looking at prog
To print this article, all you need is to be registered or login on Mondaq.com.
Most of the life science industries closely guard their trade
secret to stay ahead in the competition. These trade secrets may
include a new compound, new antibody, a new peptide or new gene.
The costs of taking protective measures to safeguard secrecy are
high and so is the cost suffered if the valuable trade secret falls
in wrong hands. For example AGC Inc an aviation component
manufacturing company based in Connecticut US became bankrupt when
their former Vice President who left them in 2009 joined their
A new antiviral drug, delivered in a single shot, could be a key tool to slow community spread, according to a Canadian study that shows the treatment may be able to help those with milder cases of COVID-19 recover from the infection much faster.